Literature DB >> 23173

The activator of cerebroside-sulphatase. A model of the activation.

G Fischer, H Jatzkewitz.   

Abstract

The activator of cereboroside-sulphatase (cerebroside-3-sulphate-3-sulphohydrolase, EC 3.1.6.8) is necessary for the enzymic hydrolysis of sulphatides (cerebroside sulphates) at ionic concentrations in the physiological range. The pH optimum of the reaction is 4.5--4.8. Under similar incubation conditions, a complex is formed between activator and sulphatides which is partially inhibited, due to competitive binding in the presence of cerebrosides of phosphatidylserine. Inhibition depends upon the concentration of the lipids and is of the same order of magnitude as the inhibition (by these lipids) of enzymic sulphatide hydrolysis in the presence of activator. Complex formation between activator and sulphatides is reversible since the complex dissociates partially when certain concentrations of phosphatidylserine are added. Moreover, the rate of sulphatide hydrolysis increases with the concentration of the activator.sulphatide complex in the reaction mixture. This indicates that the activator.sulphatide complex is the substrate for the enzyme and a model for this activation is presented.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23173     DOI: 10.1016/0005-2760(78)90053-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder.

Authors:  H Christomanou; A Chabás; T Pámpols; A Guardiola
Journal:  Klin Wochenschr       Date:  1989-10-02

3.  Saposin A: second cerebrosidase activator protein.

Authors:  S Morimoto; B M Martin; Y Yamamoto; K A Kretz; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.

Authors:  S Morimoto; Y Yamamoto; J S O'Brien; Y Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Preliminary evidence for a processing error in the biosynthesis of Gaucher activator in mucolipidosis disease types II and III.

Authors:  E Ranieri; B Paton; A Poulos
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

Review 6.  Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses.

Authors:  K Harzer; B C Paton; A Poulos; B Kustermann-Kuhn; W Roggendorf; T Grisar; M Popp
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

7.  Placental steroid deficiency: association with arylsulfatase A deficiency.

Authors:  J Vidgoff; M M Buxman; L J Shapiro; R L Dimond; T G Wilson; C A Hepburn; T Tabei; W R Heinrichs
Journal:  Am J Hum Genet       Date:  1982-05       Impact factor: 11.025

8.  The AB-variant of metachromatic leukodystrophy (postulated activator protein deficiency). Light and electron microscopic findings in a sural nerve biopsy.

Authors:  A F Hahn; B A Gordon; J J Gilbert; G G Hinton
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 9.  Properties, metabolism and roles of sulfogalactosylglycerolipid in male reproduction.

Authors:  Nongnuj Tanphaichitr; Kessiri Kongmanas; Kym F Faull; Julian Whitelegge; Federica Compostella; Naoko Goto-Inoue; James-Jules Linton; Brendon Doyle; Richard Oko; Hongbin Xu; Luigi Panza; Arpornrad Saewu
Journal:  Prog Lipid Res       Date:  2018-08-25       Impact factor: 16.195

10.  Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy.

Authors:  R L Stevens; A L Fluharty; H Kihara; M M Kaback; L J Shapiro; B Marsh; K Sandhoff; G Fischer
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.